Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
$3.99
+0.8%
$4.70
$2.92
▼
$6.45
$318.00M0.76307,434 shs342,250 shs
CCXI
Churchill Capital Corp XI
$11.52
+2.3%
$11.38
$8.00
▼
$19.69
$821.81M1.221.94 million shs4.80 million shs
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$13.99
-2.8%
$14.09
$9.77
▼
$16.33
$2.51B0.347,930 shs35,799 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
+0.76%-5.45%-9.11%-25.56%+30.82%
CCXI
Churchill Capital Corp XI
0.00%0.00%+9.90%-18.14%+1,151,699,900.00%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
-2.85%-7.23%-1.34%+11.39%-4.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
$3.99
+0.8%
$4.70
$2.92
▼
$6.45
$318.00M0.76307,434 shs342,250 shs
CCXI
Churchill Capital Corp XI
$11.52
+2.3%
$11.38
$8.00
▼
$19.69
$821.81M1.221.94 million shs4.80 million shs
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$13.99
-2.8%
$14.09
$9.77
▼
$16.33
$2.51B0.347,930 shs35,799 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
+0.76%-5.45%-9.11%-25.56%+30.82%
CCXI
Churchill Capital Corp XI
0.00%0.00%+9.90%-18.14%+1,151,699,900.00%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
-2.85%-7.23%-1.34%+11.39%-4.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
2.33
Hold$8.00100.50% Upside
CCXI
Churchill Capital Corp XI
1.00
SellN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
2.67
Moderate Buy$14.876.27% Upside

Current Analyst Ratings Breakdown

Latest CCXI, AVIR, and HCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
Boost Price TargetEqual Weight$7.00 ➝ $8.00
10/20/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
UpgradeSell (D) ➝ Sell (D+)
10/15/2026
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
Reiterated RatingSell (D-)
9/8/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
UpgradeHold ➝ Buy
9/3/2026
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
UpgradeHold ➝ Buy
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
N/AN/AN/AN/A$2.19 per shareN/A
CCXI
Churchill Capital Corp XI
$37.20M22.09N/AN/AN/A∞
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$548.51M4.45$2.62 per share5.34$7.17 per share1.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
-$158.35M-$1.95N/AN/AN/AN/A-69.91%-61.22%N/A
CCXI
Churchill Capital Corp XI
N/A-$1.89N/AN/AN/AN/AN/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
$456.91MN/AN/A63.59N/AN/AN/AN/AN/A

Latest CCXI, AVIR, and HCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/13/2026Q3 2026
CCXI
Churchill Capital Corp XI
N/A$1.96N/A$1.96N/AN/A
11/9/2026Q3 2026
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
-$0.51-$0.40+$0.11-$0.40$50.45 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
N/AN/AN/AN/AN/A
CCXI
Churchill Capital Corp XI
N/AN/AN/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
N/A
8.00
8.00
CCXI
Churchill Capital Corp XI
N/AN/AN/A
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
0.06
5.64
5.50

Institutional Ownership

CompanyInstitutional Ownership
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
86.67%
CCXI
Churchill Capital Corp XI
81.09%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
8.82%

Insider Ownership

CompanyInsider Ownership
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
21.60%
CCXI
Churchill Capital Corp XI
8.30%
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
5580.30 million62.96 millionOptionable
CCXI
Churchill Capital Corp XI
271.36 millionN/AOptionable
HUTCHMED (China) Limited Sponsored ADR stock logo
HCM
HUTCHMED
1,796174.47 million168.19 millionOptionable

Recent News About These Companies

HUTCHMED Highlights HMPL-A830 Pre-Clinical Data
HUTCHMED (AIM:HCM) Stock Looks Overvalued On Current Earnings
HUTCHMED (NASDAQ:HCM) Upgraded at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atea Pharmaceuticals stock logo

Atea Pharmaceuticals NASDAQ:AVIR

$3.99 +0.03 (+0.76%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$3.99 0.00 (0.00%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Churchill Capital Corp XI NASDAQ:CCXI

$11.52 +0.26 (+2.28%)
Closing price 11/4/2026
Extended Trading
$11.52 0.00 (0.00%)
As of 11/4/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Churchill Capital Corp XI is a blank check company.

HUTCHMED stock logo

HUTCHMED NASDAQ:HCM

$13.99 -0.41 (-2.85%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$13.90 -0.09 (-0.65%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.